Compared with those in the pCR group, the numbers of CD4+ T cells (nonregulatory), CD4+ Th1 T cells and follicular helper T cells in non-pCR patients were significantly lower, whereas the numbers of cancer-associated fibroblasts and endothelial cells were significantly greater (Fig. 4c, Supplementary Fig. 4). This evidence concerns the gene CD4 and cancer.